Indeed, we found that in the cancer cells examined, with some subtle differences noted between cells, 27HC inhibited the expression of SREBP1c and SREBP2 target genes with evidence of LXR agonist activity also being observed in some cells (Fig. 1e, Supplementary Fig. 2a and Supplementary Data 1). The gene discussed is SREBF1; the disease is cancer.